These findings are consistent with recent reports on BET inhibitor activity in lung adenocarcinoma and glioblastoma [33,34], and suggest that the role of BET proteins in regulating MYC expression may be tumor type- or cell line-specific. This evidence concerns the gene DNER and neoplasm.